PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines
dc.contributor.author | McCubrey, James A. | |
dc.date.accessioned | 2022-02-04T13:41:40Z | |
dc.date.available | 2022-02-04T13:41:40Z | |
dc.date.issued | 2017-02-20 | |
dc.identifier.doi | 10.18632/oncotarget.15542 | |
dc.identifier.issn | 1949-2553 | |
dc.identifier.uri | http://hdl.handle.net/10342/9623 | |
dc.language.iso | en_US | en_US |
dc.subject | PI3K isoform inhibition | en_US |
dc.subject | CT B-acute lymphoblastic leukemia (B-ALL) | en_US |
dc.subject | B-cell progenitor | en_US |
dc.title | PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines | en_US |
dc.type | Article | en_US |
ecu.journal.issue | 14 | en_US |
ecu.journal.name | Oncotarget | en_US |
ecu.journal.pages | 23213-23227 | en_US |
ecu.journal.volume | 8 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- McCubreyPI3KisoforminhibitionassociatedwithantiBcrAbldrugs.pdf
- Size:
- 11.04 MB
- Format:
- Adobe Portable Document Format
- Description:
- Article